Acute promyelocytic leukemia

Peter H. Wiernik*, Robert E. Gallagher, Martin S. Tallman

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

Original languageEnglish (US)
Title of host publicationNeoplastic Diseases of the Blood
PublisherSpringer International Publishing
Number of pages55
ISBN (Electronic)9783319642635
ISBN (Print)9783319642628
StatePublished - Jan 1 2018


  • All-trans retinoic acid
  • Arsenic trioxide
  • Pseudotumor cerebri
  • Translocation 15;17

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Acute promyelocytic leukemia'. Together they form a unique fingerprint.

Cite this